Literature DB >> 21336650

Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium.

Josep Mercader1, Estelle Wanecq, Jian Chen, Christian Carpéné.   

Abstract

The weight loss observed in consumers of extracts of Citrus aurantium (bitter orange) has been tentatively attributed to the lipolytic and thermogenic effects of the alkaloids abundant in the unripe fruit. Synephrine, octopamine, tyramine, and other alkaloids have been repeatedly identified and quantified in Citrus members of the Rutaceae family or in their extracts incorporated in dietary supplements for weight management. However, there are only scarce reports on their lipolytic action. This study aimed at comparing the acute lipolytic activity of synephrine, octopamine, tyramine, and N-methyltyramine in rat and human adipocytes. Maximal response to the prototypical β-adrenergic agonist isoprenaline was taken as reference in both species. In rat, octopamine was slightly more active than synephrine while tyramine and N-methyl tyramine did not stimulate-and even inhibited-lipolysis. In human adipocytes, none of these amines stimulated lipolysis when tested up to 10 μg/ml. At higher doses (≥100 μg/ml), tyramine and N-methyl tyramine induced only 20% of the maximal lipolysis and exhibited antilipolytic properties. Synephrine and octopamine were partially stimulatory at high doses. Since synephrine is more abundant than octopamine in C. aurantium, it should be the main responsible for the putative lipolytic action of the extracts claimed to mitigate obesity. Noteworthy, their common isopropyl derivative, isopropylnorsynephrine (also named isopropyloctopamine or betaphrine), was clearly lipolytic: active at 1 μg/ml and reproducing more than 60% of isoprenaline maximal effect in human adipocytes. This compound, not detected in C. aurantium, and which has few reported adverse effects to date, might be useful for in vivo triglyceride breakdown.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336650     DOI: 10.1007/s13105-011-0078-2

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  29 in total

1.  Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark).

Authors:  Takahiro Tsujita; Takeshi Takaku
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  2007-12       Impact factor: 2.000

Review 2.  Lipolytic effects of beta 1-, beta 2-, and beta 3-adrenergic agonists in white adipose tissue of mammals.

Authors:  C Carpéné; A Bousquet-Mélou; J Galitzky; M Berlan; M Lafontan
Journal:  Ann N Y Acad Sci       Date:  1998-05-15       Impact factor: 5.691

3.  The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.

Authors:  Sandy Bour; María-Carmen Iglesias-Osma; Luc Marti; Piedad Duro; María-José Garcia-Barrado; Maria-Francisca Pastor; Danielle Prévot; Virgile Visentin; Philippe Valet; Julio Moratinos; Christian Carpéné
Journal:  Eur J Pharmacol       Date:  2006-09-23       Impact factor: 4.432

4.  Adrenergic lipolysis in human adipose tissue in vitro.

Authors:  J Wenkeová; E Kuhn; M Wenke
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

5.  Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidases.

Authors:  V Visentin; N Morin; E Fontana; D Prévot; J Boucher; I Castan; P Valet; D Grujic; C Carpéné
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

6.  Determination of Citrus aurantium protoalkaloids using HPLC with acidic potassium permanganate chemiluminescence detection.

Authors:  Dane W Percy; Jacqui L Adcock; Xavier A Conlan; Neil W Barnett; Michelle E Gange; Laura K Noonan; Luke C Henderson; Paul S Francis
Journal:  Talanta       Date:  2009-10-31       Impact factor: 6.057

7.  Multiple binding sites for substrates and modulators of semicarbazide-sensitive amine oxidases: kinetic consequences.

Authors:  Andrew Holt; David J Smith; Laura Cendron; Giuseppe Zanotti; Adelio Rigo; Maria Luisa Di Paolo
Journal:  Mol Pharmacol       Date:  2007-11-07       Impact factor: 4.436

8.  Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions.

Authors:  Christine A Haller; Minjing Duan; Peyton Jacob; Neal Benowitz
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

9.  Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.

Authors:  M D Arbo; E R Larentis; V M Linck; A L Aboy; A L Pimentel; A T Henriques; E Dallegrave; S C Garcia; M B Leal; R P Limberger
Journal:  Food Chem Toxicol       Date:  2008-05-04       Impact factor: 6.023

10.  High lipolytic activity and dyslipidemia in a spontaneous hypertensive/NIH corpulent (SHR/N-cp) rat: a genetic model of obesity and type 2 diabetes mellitus.

Authors:  C Atgié; A Hadj-Sassi; L Bukowiecki; P Mauriège
Journal:  J Physiol Biochem       Date:  2009-03       Impact factor: 4.158

View more
  21 in total

1.  Problems with Citrus aurantium information in "A review on botanical species and chemical compounds with appetite suppressing properties for body weight control".

Authors:  Sidney J Stohs
Journal:  Plant Foods Hum Nutr       Date:  2013-09       Impact factor: 3.921

2.  Is there an optimal dose for dietary linoleic acid? Lessons from essential fatty acid deficiency supplementation and adipocyte functions in rats.

Authors:  Isabelle Harant-Farrugia; Jésus Garcia; Mari-Carmen Iglesias-Osma; Maria José Garcia-Barrado; Christian Carpéné
Journal:  J Physiol Biochem       Date:  2014-02-01       Impact factor: 4.158

3.  Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity.

Authors:  Jessica L Verpeut; Amy L Walters; Nicholas T Bello
Journal:  Nutr Res       Date:  2013-05-08       Impact factor: 3.315

4.  Effects of the amino acid derivatives, β-hydroxy-β-methylbutyrate, taurine, and N-methyltyramine, on triacylglycerol breakdown in fat cells.

Authors:  Mélanie Leroux; Tristan Lemery; Nathalie Boulet; Anaïs Briot; Alexia Zakaroff; Anne Bouloumié; Fernando Andrade; Patricia Pérez-Matute; Jose M Arbones-Mainar; Christian Carpéné
Journal:  J Physiol Biochem       Date:  2019-03-27       Impact factor: 4.158

5.  Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food.

Authors:  Christian Carpéné; Jean Galitzky; Chloé Belles; Alexia Zakaroff-Girard
Journal:  J Physiol Biochem       Date:  2018-07-23       Impact factor: 4.158

6.  The action of p-synephrine on hepatic carbohydrate metabolism and respiration occurs via both Ca(2+)-mobilization and cAMP production.

Authors:  Andrea Luiza de Oliveira; Jurandir Fernando Comar; Anacharis Babeto de Sá-Nakanishi; Rosane Marina Peralta; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2013-11-28       Impact factor: 3.396

7.  Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells.

Authors:  Saioa Gomez-Zorita; Karine Tréguer; Josep Mercader; Christian Carpéné
Journal:  J Physiol Biochem       Date:  2013-01-13       Impact factor: 4.158

8.  The Inhibitory Effect of Haloxylon salicornicum on Contraction of the Mouse Uterus.

Authors:  Nabila H Saleem; Valerie A Ferro; Ann M Simpson; John Igoli; Alexander I Gray; Robert M Drummond
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

Review 9.  A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects.

Authors:  Sidney J Stohs; Harry G Preuss; Mohd Shara
Journal:  Oxid Med Cell Longev       Date:  2011-08-01       Impact factor: 6.543

10.  Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells.

Authors:  Gon-Sup Kim; Hyoung Joon Park; Jong-Hwa Woo; Mi-Kyeong Kim; Phil-Ok Koh; Wongi Min; Yeoung-Gyu Ko; Chung-Hei Kim; Chung-Kil Won; Jae-Hyeon Cho
Journal:  BMC Complement Altern Med       Date:  2012-04-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.